Immunotherapy for the treatment of glioblastoma. - Wikidata - awgldk - TriplyDB

Immunotherapy for the treatment of glioblastoma.

Immunotherapy for the treatment of glioblastoma.

http://www.wikidata.org/entity/Q37980026

about

Role of exosomes/microvesicles in the nervous system and use in emerging therapies Severity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomas Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme Migration capacity of human umbilical cord mesenchymal stem cells towards glioma in vivo PD-L1 expression and prognostic impact in glioblastoma.Dendritic cell vaccine and cytokine-induced killer cell therapy for the treatment of advanced non-small cell lung cancer MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints Paediatric and adult malignant glioma: close relatives or distant cousins?Challenges in the development of a survivin vaccine (SurVaxM) for malignant glioma.Glioblastoma multiforme: State of the art and future therapeutics.Vaccine-based immunotherapy for glioblastoma.Pediatric diffuse intrinsic pontine glioma: can optimism replace pessimism?Dendritic cell-based vaccine for the treatment of malignant glioma: a systematic review.Current Studies of Immunotherapy on Glioblastoma Immunotherapeutic advancements for glioblastoma.Experimental Therapeutic Trial Design for Pediatric Brain Tumors.Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response.Rethinking immunotherapy for brain cancers in the light of cancer complexity.Geographic Variations in the Incidence of Glioblastoma and Prognostic Factors Predictive of Overall Survival in US Adults from 2004-2013.Glioblastoma under Siege: An Overview of Current Therapeutic Strategies.Rat astrocytic tumour cells are associated with an anti-inflammatory microglial phenotype in an organotypic model.Direct-Current Electric Field Distribution in the Brain for Tumor Treating Field Applications: A Simulation Study.Overexpression of p53 delivered using recombinant NDV induces apoptosis in glioma cells by regulating the apoptotic signaling pathway.Recombinant adenovirus expressing a dendritic cell-targeted melanoma surface antigen for tumor-specific immunotherapy in melanoma mice model.Chemotherapy combined with dendritic cell vaccine and cytokine-induced killer cells in the treatment of colorectal carcinoma: a meta-analysis

P2860

Q21129255-15577495-A0D4-43FC-8C0B-75282E1A687A Q26862551-8BFCCA1B-7CA7-43A5-8393-C9B8BAF2C140 Q28087485-263790B8-BF81-439E-87BC-4D4D0F2C5267 Q34095283-1345CC34-BBEA-4F66-A074-AF7B24105F5C Q36493843-72466178-E7AE-404D-B286-0B7AE9530901 Q36740905-23A1E2A7-F5CE-4F66-B3A4-E19138C2B64D Q36785139-9D25F30C-D062-4E69-A835-2211D4736B24 Q38013990-9D226752-6AC9-4875-B954-1B8500225708 Q38187480-C5836366-8DCB-4A72-8E30-B76A90E6669B Q38225874-DDDC87A2-BE6A-4AEF-BD91-BA7EBAC076CA Q38233114-44B84114-03E3-463E-88C3-59A7EE9A6C68 Q38233425-6BC48EF4-4E32-45C5-B89B-13FFBA309C73 Q38254629-D74A29A2-7B4D-4FE0-B071-A8242CF72691 Q38262914-65FB8CB2-B463-41E0-90EB-ECC3138E670A Q38358124-95A7FCB9-CC6C-428A-A733-333F5696C6D8 Q38583655-F22C2DE5-7B81-44B8-8330-5B82012EE4C3 Q38912265-27173C98-E058-46FB-9012-E188051E45B1 Q42539488-52D25DC7-02BF-4D3D-861C-359CD21C752D Q46142965-EA2344B8-C8AE-4D3A-AFC3-1CDD22AF37DF Q47553080-24A58492-FAB9-4567-8CC2-E0E02598C470 Q47711483-60595FE6-817A-4DC9-B282-B338177C5D21 Q52571345-654E2EE7-BA83-481C-BBA1-DC7F93643279 Q54219825-53C3CC0F-CCFE-4838-AB54-6F53235F6F12 Q55090825-43BC4B10-9A5C-48C1-A61E-9257E80CF00C Q59125672-9BA8B0A3-19F4-47CB-A414-F01C8CABD958

P2860

Immunotherapy for the treatment of glioblastoma.

http://www.wikidata.org/entity/Q37980026

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Immunotherapy for the treatment of glioblastoma.

@en

Immunotherapy for the treatment of glioblastoma.

@nl

type

label

Immunotherapy for the treatment of glioblastoma.

@en

Immunotherapy for the treatment of glioblastoma.

@nl

prefLabel

Immunotherapy for the treatment of glioblastoma.

@en

Immunotherapy for the treatment of glioblastoma.

@nl

P1433

Q37980026-66BA8507-C445-4A58-84D1-4736E55DF0B8

P1476

Q37980026-C8A9FDB2-57B0-4927-9F54-AB368A57D77C

P2093

Q37980026-46B3F39F-0724-432A-A71A-B760B7BE958F

Q37980026-7FAC35C8-5309-4572-9B6E-18C8B64F9860

Q37980026-891F1C49-ED88-424A-9641-F75A75DB1F46

P2860

Q37980026-078E6788-CE8F-4735-81CE-C02FA143FD12

Q37980026-0916B7AB-39A4-4F50-9CD7-811540C59D0D

Q37980026-09F18149-186D-4B85-9790-CB636E69FF8F

Q37980026-0A143BA3-554E-4DD4-9FA1-6127855B7ED3

Q37980026-104DAB44-B76E-4568-AA61-BA00C1F7CBEF

Q37980026-142536EF-F4A5-44A9-B318-E1072704023D

Q37980026-1633C397-E072-421F-80BC-98ABE4C0990A

Q37980026-1A3F1516-A1BB-4749-BC81-A394E50CF6CC

Q37980026-1B92CDEC-6282-4107-AB8B-85448B7C1C4C

Q37980026-1B96E0B7-58E7-40EF-B612-D8C2BBC3E92D

P304

Q37980026-64870BED-B80A-431A-9EE0-FBA81DF8117C

P31

Q37980026-CB0DB9F0-3AB5-465B-A5BB-E326F22E8979

P356

Q37980026-AAFE96EA-494B-4CAB-A299-39ABA94C1961

P433

Q37980026-79F66CCA-B640-4622-A60B-5088C734C4A6

P478

Q37980026-448D1FF2-9E58-4A15-9BE8-73753D97E768

P577

Q37980026-47954B28-DF0E-4A01-A979-A9BF394F6613

P698

Q37980026-E4CD75C2-9C70-4CEF-9592-F3C34E1B1478

P921

Q37980026-364F121A-4317-42E5-A056-D1E7A8A1E083

P932

Q37980026-AE8D35BA-A6E2-4637-A297-B2E8E6887B08

P356

PPO.0B013E3182431A73

P1433

The Cancer Journal

P1476

Immunotherapy for the treatment of glioblastoma.

@en

P2093

Alissa A Thomas

http://www.w3.org/2001/XMLSchema#string

Camilo E Fadul

http://www.w3.org/2001/XMLSchema#string

Marc S Ernstoff

http://www.w3.org/2001/XMLSchema#string

P2860

Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

Cancer immunotherapy

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

Clinical applications of a peptide-based vaccine for glioblastoma.

EGFRvIII-targeted vaccination therapy of malignant glioma.

Trafficking of immune cells in the central nervous system

CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor.

P304

59-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/PPO.0B013E3182431A73

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22290259

http://www.w3.org/2001/XMLSchema#string

P921

P932

3269657

http://www.w3.org/2001/XMLSchema#string